2 news items
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
EVOK
16 May 24
is at the core of our mission as a company. At DDW 2024, our poster presentation will highlight the additional benefits of GIMOTI with improving
Evoke Pharma Reports First Quarter 2024 Financial Results
EVOK
14 May 24
data on the clinical use of nasal metoclopramide in women with gastroparesis, highlighting its benefits and practical application," Mr. D'Onofrio
- Prev
- 1
- Next